메뉴 건너뛰기




Volumn 10, Issue 3, 2006, Pages 665-678

Coagulation Abnormalities in Patients Who Have Liver Disease

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA; HEPARIN; INTERFERON; MACROGOL; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; NEUTRALIZING ANTIBODY; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT INTERLEUKIN 11; RECOMBINANT THROMBOPOIETIN; THROMBOPOIETIN; VITAMIN K GROUP; WARFARIN;

EID: 33845317847     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2006.08.006     Document Type: Review
Times cited : (36)

References (86)
  • 1
    • 0028657630 scopus 로고
    • Coagulopathies of liver diseases
    • Mammen E.F. Coagulopathies of liver diseases. Clin Lab Med 14 (1994) 769-780
    • (1994) Clin Lab Med , vol.14 , pp. 769-780
    • Mammen, E.F.1
  • 2
    • 0028258375 scopus 로고
    • Coagulation defects in liver diseases
    • Mammen E.F. Coagulation defects in liver diseases. Med Clin North Am 78 (1994) 545-554
    • (1994) Med Clin North Am , vol.78 , pp. 545-554
    • Mammen, E.F.1
  • 3
    • 0026467337 scopus 로고
    • Coagulation abnormalities in liver diseases
    • Mammen E.F. Coagulation abnormalities in liver diseases. Hematol Oncol Clin North Am 8 (1992) 1247-1257
    • (1992) Hematol Oncol Clin North Am , vol.8 , pp. 1247-1257
    • Mammen, E.F.1
  • 6
    • 21344460746 scopus 로고    scopus 로고
    • The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis
    • Rios R., Sangro B., Herrero I., et al. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol 100 (2005) 1311-1316
    • (2005) Am J Gastroenterol , vol.100 , pp. 1311-1316
    • Rios, R.1    Sangro, B.2    Herrero, I.3
  • 7
    • 0344064996 scopus 로고    scopus 로고
    • Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection
    • Giannini E., Botta F., Borro P., et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 98 (2003) 2516-2520
    • (2003) Am J Gastroenterol , vol.98 , pp. 2516-2520
    • Giannini, E.1    Botta, F.2    Borro, P.3
  • 8
    • 0036845812 scopus 로고    scopus 로고
    • Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis
    • Giannini E., Borro P., Botta F., et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol 37 (2002) 572-577
    • (2002) J Hepatol , vol.37 , pp. 572-577
    • Giannini, E.1    Borro, P.2    Botta, F.3
  • 9
    • 0036841403 scopus 로고    scopus 로고
    • Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts
    • Koruk M., Onuk M.D., Akcay F., et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts. Hepatogastroenterology 49 (2002) 1645-1648
    • (2002) Hepatogastroenterology , vol.49 , pp. 1645-1648
    • Koruk, M.1    Onuk, M.D.2    Akcay, F.3
  • 10
    • 0033015909 scopus 로고    scopus 로고
    • Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis
    • Kawasaki T., Takeshita A., Souda K., et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol 94 (1999) 1918-1922
    • (1999) Am J Gastroenterol , vol.94 , pp. 1918-1922
    • Kawasaki, T.1    Takeshita, A.2    Souda, K.3
  • 11
    • 0036376859 scopus 로고    scopus 로고
    • Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size
    • Freni M.A., Spadaro A., Ajello A., et al. Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size. Hepatogastroenterology 49 (2002) 1382-1385
    • (2002) Hepatogastroenterology , vol.49 , pp. 1382-1385
    • Freni, M.A.1    Spadaro, A.2    Ajello, A.3
  • 12
    • 0036267737 scopus 로고    scopus 로고
    • Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease
    • Schoffski P., Tacke F., Trautwein C., et al. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. Liver 22 (2002) 114-120
    • (2002) Liver , vol.22 , pp. 114-120
    • Schoffski, P.1    Tacke, F.2    Trautwein, C.3
  • 13
    • 0037263550 scopus 로고    scopus 로고
    • Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation
    • Tsukahara A., Sato Y., Yamamoto S., et al. Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation. Hepatogastroenterology 50 (2003) 227-230
    • (2003) Hepatogastroenterology , vol.50 , pp. 227-230
    • Tsukahara, A.1    Sato, Y.2    Yamamoto, S.3
  • 14
    • 12944249537 scopus 로고    scopus 로고
    • Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production
    • Peck-Radosavljevic M., Wichlas M., Zacherl J., et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood 95 (2000) 795-801
    • (2000) Blood , vol.95 , pp. 795-801
    • Peck-Radosavljevic, M.1    Wichlas, M.2    Zacherl, J.3
  • 15
    • 0033042073 scopus 로고    scopus 로고
    • Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation
    • Goulis J., Chau T.N., Jordan S., et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 44 (1999) 754-758
    • (1999) Gut , vol.44 , pp. 754-758
    • Goulis, J.1    Chau, T.N.2    Jordan, S.3
  • 16
    • 0032910590 scopus 로고    scopus 로고
    • Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation
    • Peck-Radosavljevic M., Zacherl J., Wichlas M., et al. Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation. Eur J Gastroenterol Hepatol 11 (1999) 151-156
    • (1999) Eur J Gastroenterol Hepatol , vol.11 , pp. 151-156
    • Peck-Radosavljevic, M.1    Zacherl, J.2    Wichlas, M.3
  • 17
    • 0030818789 scopus 로고    scopus 로고
    • Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation
    • Martin III T.G., Somberg K.A., Meng Y.G., et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127 (1997) 285-288
    • (1997) Ann Intern Med , vol.127 , pp. 285-288
    • Martin III, T.G.1    Somberg, K.A.2    Meng, Y.G.3
  • 18
    • 0036678345 scopus 로고    scopus 로고
    • Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection
    • Pockros P.J., Duchini A., McMillan R., et al. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 97 (2002) 2040-2045
    • (2002) Am J Gastroenterol , vol.97 , pp. 2040-2045
    • Pockros, P.J.1    Duchini, A.2    McMillan, R.3
  • 19
    • 0037340514 scopus 로고    scopus 로고
    • Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases
    • Ramos-Casals M., Garcia-Carrasco M., Lopez-Medrano F., et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 82 (2003) 87-96
    • (2003) Medicine (Baltimore) , vol.82 , pp. 87-96
    • Ramos-Casals, M.1    Garcia-Carrasco, M.2    Lopez-Medrano, F.3
  • 20
    • 21744458711 scopus 로고    scopus 로고
    • Immune thrombocytopenic purpura in patients with hepatitis C virus infection
    • Nakajima H., Takagi H., Yamazaki Y., et al. Immune thrombocytopenic purpura in patients with hepatitis C virus infection. Hepatogastroenterology 52 (2005) 1197-1200
    • (2005) Hepatogastroenterology , vol.52 , pp. 1197-1200
    • Nakajima, H.1    Takagi, H.2    Yamazaki, Y.3
  • 21
    • 0031005291 scopus 로고    scopus 로고
    • Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis
    • Feistauer S.M., Penner E., Mayr W.R., et al. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology 25 (1997) 1343-1345
    • (1997) Hepatology , vol.25 , pp. 1343-1345
    • Feistauer, S.M.1    Penner, E.2    Mayr, W.R.3
  • 22
    • 27644498501 scopus 로고    scopus 로고
    • Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C
    • Lambotte O., Gelu-Simeon M., Maigne G., et al. Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. J Infect 51 (2005) e113-e115
    • (2005) J Infect , vol.51
    • Lambotte, O.1    Gelu-Simeon, M.2    Maigne, G.3
  • 23
    • 13244281650 scopus 로고    scopus 로고
    • Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab
    • Weitz J.C. Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab. Am J Hematol 78 (2005) 138-141
    • (2005) Am J Hematol , vol.78 , pp. 138-141
    • Weitz, J.C.1
  • 24
    • 5044231347 scopus 로고    scopus 로고
    • Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1
    • Dimitroulopoulos D., Dourakis S.P., Xinopoulos D., et al. Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1. J Viral Hepat 11 (2004) 477-478
    • (2004) J Viral Hepat , vol.11 , pp. 477-478
    • Dimitroulopoulos, D.1    Dourakis, S.P.2    Xinopoulos, D.3
  • 25
    • 0346749418 scopus 로고    scopus 로고
    • Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C
    • Medeiros B.C., Seligman P.A., Everson G.T., et al. Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C. J Clin Gastroenterol 38 (2004) 84-86
    • (2004) J Clin Gastroenterol , vol.38 , pp. 84-86
    • Medeiros, B.C.1    Seligman, P.A.2    Everson, G.T.3
  • 26
    • 0242266379 scopus 로고    scopus 로고
    • Is there an increased frequency of autoimmune thrombocytopenia in hepatitis C infection? A review
    • Panzer S., and Seel E. Is there an increased frequency of autoimmune thrombocytopenia in hepatitis C infection? A review. Wien Med Wochenschr 153 (2003) 417-420
    • (2003) Wien Med Wochenschr , vol.153 , pp. 417-420
    • Panzer, S.1    Seel, E.2
  • 27
    • 0038238652 scopus 로고    scopus 로고
    • Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C
    • Fujii H., Kitada T., Yamada T., et al. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C. Hepatogastroenterology 50 (2003) 841-842
    • (2003) Hepatogastroenterology , vol.50 , pp. 841-842
    • Fujii, H.1    Kitada, T.2    Yamada, T.3
  • 28
    • 0036118764 scopus 로고    scopus 로고
    • Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C
    • Sagir A., Wettstein M., Heintges T., et al. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C. Dig Dis Sci 47 (2002) 562-563
    • (2002) Dig Dis Sci , vol.47 , pp. 562-563
    • Sagir, A.1    Wettstein, M.2    Heintges, T.3
  • 29
    • 0032847122 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    • Ben-Ari Z., Osman E., Hutton R.A., et al. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?. Am J Gastroenterol 94 (1999) 2977-2982
    • (1999) Am J Gastroenterol , vol.94 , pp. 2977-2982
    • Ben-Ari, Z.1    Osman, E.2    Hutton, R.A.3
  • 30
    • 0026661270 scopus 로고
    • Disseminated intravascular coagulation in liver cirrhosis
    • Bakker C.M., Knot E.A., Stibbe J., et al. Disseminated intravascular coagulation in liver cirrhosis. J Hepatol 15 (1992) 330-335
    • (1992) J Hepatol , vol.15 , pp. 330-335
    • Bakker, C.M.1    Knot, E.A.2    Stibbe, J.3
  • 31
    • 0026145737 scopus 로고
    • Thrombin activation and increased fibrinolysis in patients with chronic liver disease
    • Paramo J.A., Rifon J., Fernandez J., et al. Thrombin activation and increased fibrinolysis in patients with chronic liver disease. Blood Coagul Fibrinolysis 2 (1991) 227-230
    • (1991) Blood Coagul Fibrinolysis , vol.2 , pp. 227-230
    • Paramo, J.A.1    Rifon, J.2    Fernandez, J.3
  • 32
    • 0022532735 scopus 로고
    • Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease
    • vanDeWater L., Carr J.M., Aronson D., et al. Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease. Blood 67 (1986) 1468-1473
    • (1986) Blood , vol.67 , pp. 1468-1473
    • vanDeWater, L.1    Carr, J.M.2    Aronson, D.3
  • 33
  • 34
    • 0025026392 scopus 로고
    • Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients
    • Cioni G., Cristani A., Mussini C., et al. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients. Ital J Gastroenterol 22 (1990) 70-74
    • (1990) Ital J Gastroenterol , vol.22 , pp. 70-74
    • Cioni, G.1    Cristani, A.2    Mussini, C.3
  • 35
    • 0029819726 scopus 로고    scopus 로고
    • Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group
    • Violl F., Basili S., Ferro D., et al. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group. Thromb Haemost 76 (1996) 177-183
    • (1996) Thromb Haemost , vol.76 , pp. 177-183
    • Violl, F.1    Basili, S.2    Ferro, D.3
  • 36
    • 12444330873 scopus 로고    scopus 로고
    • Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis
    • Kim H.K., Lee K.R., Yang J.H., et al. Plasma levels of D-dimer and soluble fibrin polymer in patients with hepatocellular carcinoma: a possible predictor of tumor thrombosis. Thromb Res 109 (2003) 125-129
    • (2003) Thromb Res , vol.109 , pp. 125-129
    • Kim, H.K.1    Lee, K.R.2    Yang, J.H.3
  • 37
    • 0034827797 scopus 로고    scopus 로고
    • Fat-soluble vitamin levels in patients with primary biliary cirrhosis
    • Phillips J.R., Angulo P., Petterson T., et al. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol 96 (2001) 2745-2750
    • (2001) Am J Gastroenterol , vol.96 , pp. 2745-2750
    • Phillips, J.R.1    Angulo, P.2    Petterson, T.3
  • 38
    • 0030612931 scopus 로고    scopus 로고
    • Plasma vitamin K1 level is decreased in primary biliary cirrhosis
    • Kowdley K.V., Emond M.J., Sadowski J.A., et al. Plasma vitamin K1 level is decreased in primary biliary cirrhosis. Am J Gastroenterol 92 (1997) 2059-2061
    • (1997) Am J Gastroenterol , vol.92 , pp. 2059-2061
    • Kowdley, K.V.1    Emond, M.J.2    Sadowski, J.A.3
  • 39
    • 0025119535 scopus 로고
    • A 21-year experience with major hemorrhage after percutaneous liver biopsy
    • McGill D.B., Rakela J., Zinsmeister A.R., et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99 (1990) 1396-1400
    • (1990) Gastroenterology , vol.99 , pp. 1396-1400
    • McGill, D.B.1    Rakela, J.2    Zinsmeister, A.R.3
  • 40
    • 0024436775 scopus 로고
    • Fibrin sealant as a plug for the post liver biopsy needle track
    • Chisholm R.A., Jones S.N., and Lees W.R. Fibrin sealant as a plug for the post liver biopsy needle track. Clin Radiol 40 (1989) 627-628
    • (1989) Clin Radiol , vol.40 , pp. 627-628
    • Chisholm, R.A.1    Jones, S.N.2    Lees, W.R.3
  • 41
    • 0344515616 scopus 로고    scopus 로고
    • Plugged-percutaneous liver biopsy in patients with impaired coagulation and ascites
    • Kamphuisen P.W., Wiersma T.G., Mulder C.J., et al. Plugged-percutaneous liver biopsy in patients with impaired coagulation and ascites. Pathophysiol Haemost Thromb 32 (2002) 190-193
    • (2002) Pathophysiol Haemost Thromb , vol.32 , pp. 190-193
    • Kamphuisen, P.W.1    Wiersma, T.G.2    Mulder, C.J.3
  • 42
    • 18944407713 scopus 로고    scopus 로고
    • Multiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpura
    • Hua B., Zou N., Wang S., et al. Multiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpura. Blood Coagul Fibrinolysis 16 (2005) 291-295
    • (2005) Blood Coagul Fibrinolysis , vol.16 , pp. 291-295
    • Hua, B.1    Zou, N.2    Wang, S.3
  • 43
    • 20244376150 scopus 로고    scopus 로고
    • A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience
    • Angiolillo A.L., Davenport V., Bonilla M.A., et al. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience. Clin Cancer Res 11 (2005) 2644-2650
    • (2005) Clin Cancer Res , vol.11 , pp. 2644-2650
    • Angiolillo, A.L.1    Davenport, V.2    Bonilla, M.A.3
  • 44
    • 0031049879 scopus 로고    scopus 로고
    • Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer
    • Fanucchi M., Glaspy J., Crawford J., et al. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N Engl J Med 336 (1997) 404-409
    • (1997) N Engl J Med , vol.336 , pp. 404-409
    • Fanucchi, M.1    Glaspy, J.2    Crawford, J.3
  • 45
    • 0036658131 scopus 로고    scopus 로고
    • Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions
    • Haznedaroglu I.C., Goker H., Turgut M., et al. Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions. Clin Appl Thromb Hemost 8 (2002) 193-212
    • (2002) Clin Appl Thromb Hemost , vol.8 , pp. 193-212
    • Haznedaroglu, I.C.1    Goker, H.2    Turgut, M.3
  • 46
    • 0035760892 scopus 로고    scopus 로고
    • Thrombocytopenia caused by the development of antibodies to thrombopoietin
    • Li J., Yang C., Xia Y., et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98 (2001) 3241-3248
    • (2001) Blood , vol.98 , pp. 3241-3248
    • Li, J.1    Yang, C.2    Xia, Y.3
  • 47
    • 1642313669 scopus 로고    scopus 로고
    • Enhanced effect of vascular endothelial growth factor, thrombopoietin peptide agonist, SCF, and Flt3-L on LTC-IC and reporter gene transduction from umbilical cord blood CD34 + cells
    • Smith S.L., Kiss J., Siatskas C., et al. Enhanced effect of vascular endothelial growth factor, thrombopoietin peptide agonist, SCF, and Flt3-L on LTC-IC and reporter gene transduction from umbilical cord blood CD34 + cells. Transfusion 44 (2004) 438-449
    • (2004) Transfusion , vol.44 , pp. 438-449
    • Smith, S.L.1    Kiss, J.2    Siatskas, C.3
  • 48
    • 19944432021 scopus 로고    scopus 로고
    • Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist
    • Erickson-Miller C.L., DeLorme E., Tian S.S., et al. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist. Exp Hematol 33 (2005) 85-93
    • (2005) Exp Hematol , vol.33 , pp. 85-93
    • Erickson-Miller, C.L.1    DeLorme, E.2    Tian, S.S.3
  • 49
    • 0036942861 scopus 로고    scopus 로고
    • Recombinant human interleukin-11 reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation
    • Ferrari S., Danova M., Porta C., et al. Recombinant human interleukin-11 reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation. Ann Hematol 81 (2002) 354-356
    • (2002) Ann Hematol , vol.81 , pp. 354-356
    • Ferrari, S.1    Danova, M.2    Porta, C.3
  • 50
    • 12344288374 scopus 로고    scopus 로고
    • Low-dose interleukin-11 in patients with bone marrow failure: update of the M.D. Anderson Cancer Center experience
    • Tsimberidou A.M., Giles F.J., Khouri I., et al. Low-dose interleukin-11 in patients with bone marrow failure: update of the M.D. Anderson Cancer Center experience. Ann Oncol 16 (2005) 139-145
    • (2005) Ann Oncol , vol.16 , pp. 139-145
    • Tsimberidou, A.M.1    Giles, F.J.2    Khouri, I.3
  • 51
    • 0038036517 scopus 로고    scopus 로고
    • Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis
    • Ghalib R., Levine C., Hassan M., et al. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis. Hepatology 37 (2003) 1165-1171
    • (2003) Hepatology , vol.37 , pp. 1165-1171
    • Ghalib, R.1    Levine, C.2    Hassan, M.3
  • 52
    • 0036952236 scopus 로고    scopus 로고
    • Interleukin-11 administration normalizes the platelet count in a hypersplenic cirrhotic patient
    • Ustun C., Dainer P.M., and Faguet G.B. Interleukin-11 administration normalizes the platelet count in a hypersplenic cirrhotic patient. Ann Hematol 81 (2002) 609-610
    • (2002) Ann Hematol , vol.81 , pp. 609-610
    • Ustun, C.1    Dainer, P.M.2    Faguet, G.B.3
  • 53
    • 1642546196 scopus 로고    scopus 로고
    • Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension
    • Kercher K.W., Carbonell A.M., Heniford B.T., et al. Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension. J Gastrointest Surg 8 (2004) 120-126
    • (2004) J Gastrointest Surg , vol.8 , pp. 120-126
    • Kercher, K.W.1    Carbonell, A.M.2    Heniford, B.T.3
  • 54
    • 0345330205 scopus 로고    scopus 로고
    • Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma
    • Cao Z.X., Chen X.P., and Wu Z.D. Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma. World J Gastroenterol 9 (2003) 2460-2463
    • (2003) World J Gastroenterol , vol.9 , pp. 2460-2463
    • Cao, Z.X.1    Chen, X.P.2    Wu, Z.D.3
  • 55
    • 4444282984 scopus 로고    scopus 로고
    • Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia
    • Wu C.C., Cheng S.B., Ho W.M., et al. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery 136 (2004) 660-668
    • (2004) Surgery , vol.136 , pp. 660-668
    • Wu, C.C.1    Cheng, S.B.2    Ho, W.M.3
  • 56
    • 20044378281 scopus 로고    scopus 로고
    • Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients
    • N'Kontchou G., Seror O., Bourcier V., et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 17 (2005) 179-184
    • (2005) Eur J Gastroenterol Hepatol , vol.17 , pp. 179-184
    • N'Kontchou, G.1    Seror, O.2    Bourcier, V.3
  • 57
    • 0027313010 scopus 로고
    • Partial splenic embolization for the treatment of hypersplenism in cirrhosis
    • Sangro B., Bilbao I., Herrero I., et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 18 (1993) 309-314
    • (1993) Hepatology , vol.18 , pp. 309-314
    • Sangro, B.1    Bilbao, I.2    Herrero, I.3
  • 58
    • 16344384956 scopus 로고    scopus 로고
    • An audit of the indications for and techniques of palliative splenic radiotherapy in the UK
    • Jyothirmayi R., and Coltart S. An audit of the indications for and techniques of palliative splenic radiotherapy in the UK. Clin Oncol (R Coll Radiol) 17 (2005) 192-194
    • (2005) Clin Oncol (R Coll Radiol) , vol.17 , pp. 192-194
    • Jyothirmayi, R.1    Coltart, S.2
  • 59
    • 0030992726 scopus 로고    scopus 로고
    • Splenic irradiation for the treatment of hypersplenism from congestive splenomegaly
    • Kenawi M.M., el-Ghamrawi K.A., Mohammad A.A., et al. Splenic irradiation for the treatment of hypersplenism from congestive splenomegaly. Br J Surg 84 (1997) 860-861
    • (1997) Br J Surg , vol.84 , pp. 860-861
    • Kenawi, M.M.1    el-Ghamrawi, K.A.2    Mohammad, A.A.3
  • 60
    • 0028904063 scopus 로고
    • Congestive hypersplenism: treatment by means of radioembolization of the spleen with Y-90
    • Becker C.D., Rosler H., Biasiutti F.D., et al. Congestive hypersplenism: treatment by means of radioembolization of the spleen with Y-90. Radiology 195 (1995) 183-186
    • (1995) Radiology , vol.195 , pp. 183-186
    • Becker, C.D.1    Rosler, H.2    Biasiutti, F.D.3
  • 61
    • 0029897388 scopus 로고    scopus 로고
    • Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS)
    • Jalan R., Redhead D.N., Allan P.L., et al. Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 8 (1996) 381-385
    • (1996) Eur J Gastroenterol Hepatol , vol.8 , pp. 381-385
    • Jalan, R.1    Redhead, D.N.2    Allan, P.L.3
  • 62
    • 0030997274 scopus 로고    scopus 로고
    • Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism
    • Pursnani K.G., Sillin L.F., and Kaplan D.S. Effect of transjugular intrahepatic portosystemic shunt on secondary hypersplenism. Am J Surg 173 (1997) 169-173
    • (1997) Am J Surg , vol.173 , pp. 169-173
    • Pursnani, K.G.1    Sillin, L.F.2    Kaplan, D.S.3
  • 63
    • 0029148142 scopus 로고
    • Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis
    • Lawrence S.P., Lezotte D.C., and Durham J.D. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40 (1995) 1575-1580
    • (1995) Dig Dis Sci , vol.40 , pp. 1575-1580
    • Lawrence, S.P.1    Lezotte, D.C.2    Durham, J.D.3
  • 64
    • 0030024001 scopus 로고    scopus 로고
    • Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
    • Alvarez O.A., Lopera G.A., Patel V., et al. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91 (1996) 134-137
    • (1996) Am J Gastroenterol , vol.91 , pp. 134-137
    • Alvarez, O.A.1    Lopera, G.A.2    Patel, V.3
  • 65
    • 0032960950 scopus 로고    scopus 로고
    • Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt-a prospective, controlled study
    • Gschwantler M., Vavrik J., Gebauer A., et al. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt-a prospective, controlled study. J Hepatol 30 (1999) 254-259
    • (1999) J Hepatol , vol.30 , pp. 254-259
    • Gschwantler, M.1    Vavrik, J.2    Gebauer, A.3
  • 66
    • 0033732227 scopus 로고    scopus 로고
    • Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis
    • Karasu Z., Gurakar A., Kerwin B., et al. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 45 (2000) 1971-1976
    • (2000) Dig Dis Sci , vol.45 , pp. 1971-1976
    • Karasu, Z.1    Gurakar, A.2    Kerwin, B.3
  • 67
    • 0031772387 scopus 로고    scopus 로고
    • Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
    • Jabbour N., Zajko A., Orons P., et al. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?. Dig Dis Sci 43 (1998) 2459-2462
    • (1998) Dig Dis Sci , vol.43 , pp. 2459-2462
    • Jabbour, N.1    Zajko, A.2    Orons, P.3
  • 68
    • 0034137472 scopus 로고    scopus 로고
    • The use and misuse of transjugular intrahepatic portasystemic shunts
    • Sanyal A.J. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep 2 (2000) 61-71
    • (2000) Curr Gastroenterol Rep , vol.2 , pp. 61-71
    • Sanyal, A.J.1
  • 69
    • 0038649821 scopus 로고    scopus 로고
    • Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study
    • Youssef W.I., Salazar F., Dasarathy S., et al. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. Am J Gastroenterol 98 (2003) 1391-1394
    • (2003) Am J Gastroenterol , vol.98 , pp. 1391-1394
    • Youssef, W.I.1    Salazar, F.2    Dasarathy, S.3
  • 70
    • 0037711915 scopus 로고    scopus 로고
    • Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy
    • Anantharaju A., Mehta K., Mindikoglu A.L., et al. Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci 48 (2003) 1414-1424
    • (2003) Dig Dis Sci , vol.48 , pp. 1414-1424
    • Anantharaju, A.1    Mehta, K.2    Mindikoglu, A.L.3
  • 71
    • 0037338514 scopus 로고    scopus 로고
    • Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient
    • Mindikoglu A.L., Anantharaju A., Villanueva J., et al. Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient. Chest 123 (2003) 956-958
    • (2003) Chest , vol.123 , pp. 956-958
    • Mindikoglu, A.L.1    Anantharaju, A.2    Villanueva, J.3
  • 72
    • 0036302232 scopus 로고    scopus 로고
    • Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy
    • Jeffers L., Chalasani N., Balart L., et al. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 123 (2002) 118-126
    • (2002) Gastroenterology , vol.123 , pp. 118-126
    • Jeffers, L.1    Chalasani, N.2    Balart, L.3
  • 73
    • 0037320717 scopus 로고    scopus 로고
    • Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy
    • Shami V.M., Caldwell S.H., and Hespenheide E.E. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 9 (2003) 138-143
    • (2003) Liver Transpl , vol.9 , pp. 138-143
    • Shami, V.M.1    Caldwell, S.H.2    Hespenheide, E.E.3
  • 74
    • 0034863405 scopus 로고    scopus 로고
    • Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices
    • Ejlersen E., Melsen T., Ingerslev J., et al. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 36 (2001) 1081-1085
    • (2001) Scand J Gastroenterol , vol.36 , pp. 1081-1085
    • Ejlersen, E.1    Melsen, T.2    Ingerslev, J.3
  • 75
    • 0842264847 scopus 로고    scopus 로고
    • Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices
    • Romero-Castro R., Jimenez-Saenz M., Pellicer-Bautista F., et al. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. Clin Gastroenterol Hepatol 2 (2004) 78-84
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 78-84
    • Romero-Castro, R.1    Jimenez-Saenz, M.2    Pellicer-Bautista, F.3
  • 76
    • 5144222624 scopus 로고    scopus 로고
    • Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial
    • Bosch J., Thabut D., Bendtsen F., et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127 (2004) 1123-1130
    • (2004) Gastroenterology , vol.127 , pp. 1123-1130
    • Bosch, J.1    Thabut, D.2    Bendtsen, F.3
  • 77
    • 23744438763 scopus 로고    scopus 로고
    • Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease
    • Planinsic R.M., van der Meer J., Testa G., et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 11 (2005) 895-900
    • (2005) Liver Transpl , vol.11 , pp. 895-900
    • Planinsic, R.M.1    van der Meer, J.2    Testa, G.3
  • 78
    • 23744440522 scopus 로고    scopus 로고
    • Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation
    • Lodge J.P.A., Jonas S., Jones R.M., et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 11 (2005) 973-979
    • (2005) Liver Transpl , vol.11 , pp. 973-979
    • Lodge, J.P.A.1    Jonas, S.2    Jones, R.M.3
  • 79
    • 0027958326 scopus 로고
    • The international normalized ratio
    • Hirsh J., and Poller L. The international normalized ratio. Arch Intern Med 154 (1994) 282-288
    • (1994) Arch Intern Med , vol.154 , pp. 282-288
    • Hirsh, J.1    Poller, L.2
  • 81
    • 0029912013 scopus 로고    scopus 로고
    • Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio
    • Robert A., and Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio. Hepatology 24 (1996) 1392-1394
    • (1996) Hepatology , vol.24 , pp. 1392-1394
    • Robert, A.1    Chazouilleres, O.2
  • 82
    • 0028365539 scopus 로고
    • Assessment of the validity of the INR system for patients with liver impairment
    • Kovacs M.H., Wong A., MacKinnon K., et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost 71 (1994) 727-730
    • (1994) Thromb Haemost , vol.71 , pp. 727-730
    • Kovacs, M.H.1    Wong, A.2    MacKinnon, K.3
  • 83
    • 0033562928 scopus 로고    scopus 로고
    • Comparative studies of rabbit and human recombinant tissue factor reagents
    • Denson K.W.E., Reed S.V., Haddon M.E., et al. Comparative studies of rabbit and human recombinant tissue factor reagents. Thromb Res 94 (1999) 255-261
    • (1999) Thromb Res , vol.94 , pp. 255-261
    • Denson, K.W.E.1    Reed, S.V.2    Haddon, M.E.3
  • 84
    • 4544373091 scopus 로고    scopus 로고
    • Hemostatic disorders in liver disease
    • Schiff E.R., Sorrell M.F., and Maddrey W.C. (Eds), Lippincott Williams and Wilkins, Philadelphia
    • Hedner U., and Erhardtsen E. Hemostatic disorders in liver disease. In: Schiff E.R., Sorrell M.F., and Maddrey W.C. (Eds). Diseases of the liver (2003), Lippincott Williams and Wilkins, Philadelphia 625-635
    • (2003) Diseases of the liver , pp. 625-635
    • Hedner, U.1    Erhardtsen, E.2
  • 85
    • 0037223652 scopus 로고    scopus 로고
    • Model for end-stage liver disease (MELD) and allocation of donor liver
    • Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor liver. Gastroenterology 124 (2003) 91-96
    • (2003) Gastroenterology , vol.124 , pp. 91-96
    • Wiesner, R.1    Edwards, E.2    Freeman, R.3
  • 86
    • 4544300925 scopus 로고    scopus 로고
    • Specific laboratory methodologies achieve higher Model for Endstage Liver Disease (MELD) scores for patients listed for liver transplantation
    • R
    • Trotter J.F., Brimhall B., Arjal R., et al. Specific laboratory methodologies achieve higher Model for Endstage Liver Disease (MELD) scores for patients listed for liver transplantation. Liver Transpl (2004) R
    • (2004) Liver Transpl
    • Trotter, J.F.1    Brimhall, B.2    Arjal, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.